Synthesis and characterization of respiratory syncytial virus protein G related peptides containing two disulphide bridges.
Respiratory Syncytial Virus (RSV) is the most important cause of bronchiolitis and viral pneumoniae in infants and young children. Approximately 100,000 children are hospitalized in the USA each year as a result of RSV infections. During the research and development of subunit human RSV vaccines, we have produced numerous synthetic peptides and recombinant proteins containing the four cysteines of the highly conserved central region of the G attachment protein. For several of these disulphide bridges containing peptides, all possible oxidizing isomers were synthesized using various oxidising conditions, resulting in different ratios of isomers. Each isolated isomer was fully characterized by RP-HPLC, FZCE and ES-MS after purification by preparative RP-HPLC. The different cysteine pairings were unambiguously established after enzymatic digestion, LC-MS analysis and peptide microsequencing. These synthetic and analytical methods were developed for the characterization of recombinant fusion protein BBG2Na which is currently investigated in clinical phase II and seems to be as a very promising vaccine candidate, and for peptides which were synthesized to be evaluated as conjugate vaccines or as immunochemical tools, after covalent coupling to carrier proteins. Furthermore, these studies allowed us to determine which of the different possible isomers was the most stable and probably the preferred form in native conditions. Finally, the different oxidising and analysis conditions, should be useful for disulphide pairing studies of other peptides and proteins having the same "xCxxCxxxxxCxxxCx" framework, such as G proteins of non-human RSV strains, developed for example as veterinary vaccine candidates.
Beck
A
A
Centre d'Immunologie Pierre Fabre, Saint-Julien-en-Genevois, France.
Zorn
N
N
Bussat
M C
MC
Haeuw
J F
JF
Corvaïa
N
N
Nguyen
T N
TN
Van Dorsselaer
A
A
Bonnefoy
J Y
JY
D002853:Chromatography, Liquid; D004220:Disulfides / Q000138:chemical synthesis*; D013058:Mass Spectrometry; D010455:Peptides / Q000138:chemical synthesis / Q000276:immunology; D011994:Recombinant Proteins / Q000138:chemical synthesis / Q000737:chemistry / Q000276:immunology; D018113:Respiratory Syncytial Virus, Human / Q000737:chemistry* / Q000276:immunology; D014759:Viral Envelope Proteins / Q000138:chemical synthesis* / Q000276:immunology; D014765:Viral Vaccines / Q000138:chemical synthesis / Q000737:chemistry / Q000276:immunology
D004220:Disulfides; C066028:G protein, Bovine respiratory syncytial virus; D010455:Peptides; D011994:Recombinant Proteins; D014759:Viral Envelope Proteins; D014765:Viral Vaccines